GlassScriptPhysician profile
David Alexander Kaufman
NPI 1629000849
$20,444.51
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,348 · 2020: $2,023 · 2021: $3,026 · 2022: $39.59 · 2023: $5,838 · 2024: $3,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,941 · Honoraria: $1,800 · Travel and Lodging: $1,087 · Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,941.00 |
| Honoraria | $1,800.00 |
| Travel and Lodging | $1,087.43 |
| Food and Beverage | $180.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics International LTD | $7,208.99 | 2023-2024 | |
| Getinge USA Sales, LLC | $4,716.90 | 2019-2020 | |
| Maquet Cardiovascular L.L.C. | $3,436.74 | 2019 | |
| Rigel Pharmaceuticals, INC. | $3,000.00 | 2021 | |
| Maquet Critical Care Ab | $1,800.00 | 2024 | |
| Vapotherm INC | $183.55 | 2019-2020 | |
| Csl Behring | $39.59 | 2022 | |
| Merck Sharp & Dohme LLC | $32.97 | 2019 | |
| Pfizer INC. | $25.77 | 2021 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.